"By bringing Alzheimer's blood-based biomarker testing into primary care, we can help patients and their clinicians get answers sooner." ...
Nearly 7 million Americans are living with Alzheimer's disease and that number is projected to rise to nearly 13 million.
Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer's disease by measuring proteins linked to the condition. The new test, known ...